Ensysce Biosciences, Inc. - 8-K Filing
Jeffrey Millard resigns as Chief Operating Officer of Ensysce Biosciences effective July 10, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $ENSC